NASDAQ: BBIO · Health Care / Biotechnology: Pharmaceutical Preparations

BridgeBio Pharma Inc.

How BridgeBio Pharma Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$13.8B

Price

$70.73

P/E

-24.5

EPS (TTM)

$-2.89

1-year return

6.2%

Dividend yield

0.0%

52-week range

$63.30–$70.73

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources